PHS
NOVN

PFM Health Sciences’s Novan, Inc. Common Stock NOVN Stock Holding History

PFM Health Sciences’s Portfolio NOVN Stock Details NOVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-34,163
Closed -$9.23M – 124
2016
Q4 		$9.23M Sell
34,163
-7,638
-18% -$1.76M 0.26% 82
2016
Q3 		$8.44M Buy
+41,801
New +$8.74M 0.25% 74

Other funds holding NOVN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

PFM Health Sciences's NOVN Position: Q1 2017 in Review

PFM Health Sciences sold out of Novan, Inc. Common Stock (NOVN) in Q1 2017, closing a stake of 34,163 shares — an estimated $9.23M sold.

PFM Health Sciences first reported a position in NOVN in Q3 2016 and held it in 2 quarters. The position peaked at $9.23M in Q4 2016. 38 funds tracked by Wall St. Rank hold NOVN as of Q1 2017.

  • PFM Health Sciences reported no remaining Novan, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • PFM Health Sciences sold 34,163 Novan, Inc. Common Stock shares in Q1 2017, an estimated $9.23M.
  • PFM Health Sciences first reported a position in Novan, Inc. Common Stock in Q3 2016 and held it in 2 quarters.
  • PFM Health Sciences's Novan, Inc. Common Stock position peaked at $9.23M in Q4 2016.
  • 38 funds tracked by Wall St. Rank held Novan, Inc. Common Stock as of Q1 2017.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.